Jyrki Katainen, the European Commission’s vice-president for growth and competitiveness, has called for fast progress on the extension of the European Fund for Strategic Investments.
The Commission published a press release on 31 August highlighting recent loans provided by Efsi. These included €25 million to an Austrian biotech company to support the development of cancer treatments, and €8m to a Swedish software developer to fund R&D, among other activities.
In a statement, Katainen said that these loans demonstrated the quality of the investments made possible by Efsi, as well as the need for the European Parliament and European Council to quickly approve a proposed extension of the fund.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.